{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:03:21Z","timestamp":1791302601525,"version":"4.1.0"},"reference-count":132,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"Sanofi Pasteur MSD, France"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12879-017-2445-2","type":"journal-article","created":{"date-parts":[[2017,5,18]],"date-time":"2017-05-18T12:54:39Z","timestamp":1495112079000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":82,"title":["Estimation of the burden of varicella in Europe before the introduction of universal childhood immunization"],"prefix":"10.1186","volume":"17","author":[{"given":"Margarita","family":"Riera-Montes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7704-0527","authenticated-orcid":false,"given":"Kaatje","family":"Bollaerts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Heininger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niel","family":"Hens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Gabutti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angel","family":"Gil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bayad","family":"Nozad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grazina","family":"Mirinaviciute","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elmira","family":"Flem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Souverain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Verstraeten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Hartwig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,5,18]]},"reference":[{"key":"2445_CR1","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1128\/CMR.9.3.361","volume":"9","author":"AM Arvin","year":"1996","unstructured":"Arvin AM. Varicella-zoster virus. Clin Microbiol Rev. 1996;9:361\u201381.","journal-title":"Clin Microbiol Rev"},{"key":"2445_CR2","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1741-7015-7-26","volume":"7","author":"P Bonanni","year":"2009","unstructured":"Bonanni P, Breuer J, Gershon A, et al. Varicella vaccination in Europe - taking the practical approach. BMC Med. 2009;7:26.","journal-title":"BMC Med"},{"key":"2445_CR3","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1016\/j.vaccine.2015.03.055","volume":"33","author":"IG Helmuth","year":"2015","unstructured":"Helmuth IG, Poulsen A, Suppli CH, Molbak K. Varicella in Europe-a review of the epidemiology and experience with vaccination. Vaccine. 2015;33:2406\u201313.","journal-title":"Vaccine"},{"key":"2445_CR4","unstructured":"European Centre for Disease Prevention and Control (ECDC). ECDC guidance: Varicella vaccination in the European Union, 2015. Available from: http:\/\/ecdc.europa.eu\/en\/publications\/Publications\/Varicella-Guidance-2015.pdf ."},{"key":"2445_CR5","unstructured":"EUVAC.NET. Surveillance of Varicella and Herpes Zoster in Europe, November 2010. Available from: http:\/\/ecdc.europa.eu\/en\/publications\/Publications\/varicella_zoster_report_2009_euvacnet.pdf ."},{"key":"2445_CR6","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/s00431-005-1637-8","volume":"164","author":"J Bonhoeffer","year":"2005","unstructured":"Bonhoeffer J, Baer G, Muehleisen B, et al. Prospective surveillance of hospitalisations associated with varicella-zoster virus infections in children and adolescents. Eur J Pediatr. 2005;164:366\u201370.","journal-title":"Eur J Pediatr"},{"key":"2445_CR7","doi-asserted-by":"crossref","first-page":"99","DOI":"10.21101\/cejph.a3572","volume":"18","author":"M Socan","year":"2010","unstructured":"Socan M. Evaluation of mandatory case-based reporting system for varicella in the prevaccine era. Cent Eur J Public Health. 2010;18:99\u2013103.","journal-title":"Cent Eur J Public Health"},{"key":"2445_CR8","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1023\/A:1020066806544","volume":"17","author":"DM Fleming","year":"2001","unstructured":"Fleming DM, Schellevis FG, Falcao I, Alonso TV, Padilla ML. The incidence of chickenpox in the community. Lessons for disease surveillance in sentinel practice networks. Eur J Epidemiol. 2001;17:1023\u20137.","journal-title":"Eur J Epidemiol"},{"key":"2445_CR9","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.jclinepi.2011.11.014","volume":"65","author":"D Hoy","year":"2012","unstructured":"Hoy D, Brooks P, Woolf A, et al. Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement. J Clin Epidemiol. 2012;65:934\u20139.","journal-title":"J Clin Epidemiol"},{"key":"2445_CR10","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1017\/S0950268802006878","volume":"128","author":"ML Ciofi Degli Atti","year":"2002","unstructured":"Ciofi Degli Atti ML, Rota MC, Mandolini D, et al. Assessment of varicella underreporting in Italy. Epidemiol Infect. 2002;128:479\u201384.","journal-title":"Epidemiol Infect"},{"key":"2445_CR11","unstructured":"WHO European Detailed Mortality Database. WHO Regional Office for Europe. Available at: http:\/\/data.euro.who.int\/dmdb\/ ."},{"key":"2445_CR12","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.epidem.2014.12.005","volume":"11","author":"E Santermans","year":"2015","unstructured":"Santermans E, Goeyvaerts N, Melegaro A, et al. The social contact hypothesis under the assumption of endemic equilibrium: elucidating the transmission potential of VZV in Europe. Epidemics. 2015;11:14\u201323.","journal-title":"Epidemics"},{"key":"2445_CR13","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1017\/S0950268809990896","volume":"138","author":"R Silhol","year":"2010","unstructured":"Silhol R, Alvarez FP, Arena C, et al. Micro and macro population effects in disease transmission: the case of varicella. Epidemiol Infect. 2010;138:482\u201390.","journal-title":"Epidemiol Infect"},{"key":"2445_CR14","unstructured":"European Commission. Eurostat database. Available at: http:\/\/ec.europa.eu\/eurostat\/data\/database ."},{"key":"2445_CR15","unstructured":"WHO Global Health Expenditure Database. Available at http:\/\/apps.who.int\/nha\/database\/Home\/Index\/en ."},{"key":"2445_CR16","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1186\/s12879-016-1581-4","volume":"16","author":"G Rimseliene","year":"2016","unstructured":"Rimseliene G, Vainio K, Gibory M, Salamanca BV, Flem E. Varicella-zoster virus susceptibility and primary healthcare consultations in Norway. BMC Infect Dis. 2016;16:254.","journal-title":"BMC Infect Dis"},{"key":"2445_CR17","unstructured":"Instituto de Salud Carlos III. Centro Nacional de Epidemiolog\u00eda. Estudio seroepidemiol\u00f3gico: situaci\u00f3n de las enfermedades vacunables en Espa\u00f1a. Available from: http:\/\/www.isciii.es\/ISCIII\/es\/contenidos\/fd-servicios-cientifico-tecnicos\/fd-vigilancias-alertas\/fd-enfermedades\/SEROEPIDEMIOLOGICO.pdf ."},{"key":"2445_CR18","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1016\/S0264-410X(01)00035-4","volume":"19","author":"C Aebi","year":"2001","unstructured":"Aebi C, Fischer K, Gorgievski M, Matter L, Muhlemann K. Age-specific seroprevalence to varicella-zoster virus: study in Swiss children and analysis of European data. Vaccine. 2001;19:3097\u2013103.","journal-title":"Vaccine"},{"key":"2445_CR19","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1471-0528.2004.00320.x","volume":"112","author":"A Alanen","year":"2005","unstructured":"Alanen A, Kahala K, Vahlberg T, Koskela P, Vainionpaa R. Seroprevalence, incidence of prenatal infections and reliability of maternal history of varicella zoster virus, cytomegalovirus, herpes simplex virus and parvovirus B19 infection in south-western Finland. BJOG. 2005;112:50\u20136.","journal-title":"BJOG"},{"key":"2445_CR20","doi-asserted-by":"crossref","first-page":"6086","DOI":"10.1016\/j.vaccine.2007.05.019","volume":"25","author":"V Alfonsi","year":"2007","unstructured":"Alfonsi V, Montomoli E, Manini I, et al. Susceptibility to varicella in childbearing age women, Central Italy: is there a need for vaccinating this population group? Vaccine. 2007;25:6086\u20138.","journal-title":"Vaccine"},{"key":"2445_CR21","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1016\/j.vaccine.2004.03.073","volume":"23","author":"G Baer","year":"2005","unstructured":"Baer G, Bonhoeffer J, Schaad UB, Heininger U. Seroprevalence and immunization history of selected vaccine preventable diseases in medical students. Vaccine. 2005;23:2016\u201320.","journal-title":"Vaccine"},{"key":"2445_CR22","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/j.vaccine.2004.10.003","volume":"23","author":"JR De Juanes","year":"2005","unstructured":"De Juanes JR, Gil A, San-Martin M, Gonzalez A, Esteban J, Garcia de Codes A. Seroprevalence of varicella antibodies in healthcare workers and health sciences students. Reliability of self-reported history of varicella. Vaccine. 2005;23:1434\u20136.","journal-title":"Vaccine"},{"key":"2445_CR23","doi-asserted-by":"crossref","first-page":"3946","DOI":"10.1016\/j.vaccine.2006.02.017","volume":"24","author":"H Melker de","year":"2006","unstructured":"de Melker H, Berbers G, Hahne S, et al. The epidemiology of varicella and herpes zoster in The Netherlands: implications for varicella zoster virus vaccination. Vaccine. 2006;24:3946\u201352.","journal-title":"Vaccine"},{"key":"2445_CR24","doi-asserted-by":"crossref","first-page":"204","DOI":"10.4161\/hv.1.5.2216","volume":"1","author":"J Diez-Domingo","year":"2005","unstructured":"Diez-Domingo J, Gil A, San-Martin M, et al. Seroprevalence of varicella among children and adolescents in Valencia, Spain. Reliability of the parent\u2019s reported history and the medical file for identification of potential candidates for vaccination. Hum Vaccin. 2005;1:204\u20136.","journal-title":"Hum Vaccin."},{"key":"2445_CR25","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1053\/jhin.2002.1222","volume":"51","author":"U Fedeli","year":"2002","unstructured":"Fedeli U, Zanetti C, Saia B. Susceptibility of healthcare workers to measles, mumps rubella and varicella. J Hosp Infect. 2002;51:133\u20135.","journal-title":"J Hosp Infect"},{"key":"2445_CR26","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1017\/S0950268801005398","volume":"126","author":"G Gabutti","year":"2001","unstructured":"Gabutti G, Penna C, Rossi M, et al. The seroepidemiology of varicella in Italy. Epidemiol Infect. 2001;126:433\u201340.","journal-title":"Epidemiol Infect"},{"key":"2445_CR27","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1186\/1471-2458-8-372","volume":"8","author":"G Gabutti","year":"2008","unstructured":"Gabutti G, Rota MC, Guido M, et al. The epidemiology of Varicella zoster virus infection in Italy. BMC Public Health. 2008;8:372.","journal-title":"BMC Public Health"},{"key":"2445_CR28","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1093\/occmed\/46.4.289","volume":"46","author":"J Gallagher","year":"1996","unstructured":"Gallagher J, Quaid B, Cryan B. Susceptibility to varicella zoster virus infection in health care workers. Occup Med (Lond). 1996;46:289\u201392.","journal-title":"Occup Med (Lond)"},{"key":"2445_CR29","first-page":"53","volume":"36","author":"A Gil","year":"1998","unstructured":"Gil A, Gonzalez A, Dal-Re R, Ortega P, Dominguez V. Prevalence of antibodies against varicella zoster, herpes simplex (types 1 and 2), hepatitis B and hepatitis a viruses among Spanish adolescents. J Inf Secur. 1998;36:53\u20136.","journal-title":"J Inf Secur"},{"key":"2445_CR30","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jcv.2011.10.007","volume":"53","author":"M Guido","year":"2012","unstructured":"Guido M, Tinelli A, De Donno A, et al. Susceptibility to varicella-zoster among pregnant women in the province of Lecce, Italy. J Clin Virol. 2012;53:72\u20136.","journal-title":"J Clin Virol"},{"key":"2445_CR31","first-page":"252","volume":"135","author":"U Heininger","year":"2005","unstructured":"Heininger U, Baer G, Bonhoeffer J, Schaad UB. Reliability of varicella history in children and adolescents. Swiss Med Wkly. 2005;135:252\u20135.","journal-title":"Swiss Med Wkly"},{"key":"2445_CR32","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1097\/00006454-200108000-00011","volume":"20","author":"U Heininger","year":"2001","unstructured":"Heininger U, Braun-Fahrlander C, Desgrandchamps D, et al. Seroprevalence of varicella-zoster virus immunoglobulin G antibodies in Swiss adolescents and risk factor analysis for seronegativity. Pediatr Infect Dis J. 2001;20:775\u20138.","journal-title":"Pediatr Infect Dis J"},{"key":"2445_CR33","doi-asserted-by":"crossref","first-page":"3258","DOI":"10.1016\/j.vaccine.2006.01.026","volume":"24","author":"U Heininger","year":"2006","unstructured":"Heininger U, Desgrandchamps D, Schaad UB. Seroprevalence of Varicella-zoster virus IgG antibodies in Swiss children during the first 16 months of age. Vaccine. 2006;24:3258\u201360.","journal-title":"Vaccine"},{"key":"2445_CR34","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S1201-9712(03)90106-8","volume":"7","author":"J Kavaliotis","year":"2003","unstructured":"Kavaliotis J, Petridou S, Karabaxoglou D. How reliable is the history of chickenpox? Varicella serology among children up to 14 years of age. Int J Infect Dis. 2003;7:274\u20137.","journal-title":"Int J Infect Dis"},{"key":"2445_CR35","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/01.inf.0000195636.43584.bb","volume":"25","author":"B Khoshnood","year":"2006","unstructured":"Khoshnood B, Debruyne M, Lancon F, et al. Seroprevalence of varicella in the French population. Pediatr Infect Dis J. 2006;25:41\u20134.","journal-title":"Pediatr Infect Dis J"},{"key":"2445_CR36","first-page":"344","volume":"7","author":"SJ Knowles","year":"2004","unstructured":"Knowles SJ, Grundy K, Cahill I, Cafferkey MT. Susceptibility to infectious rash illness in pregnant women from diverse geographical regions. Commun Dis Public Health. 2004;7:344\u20138.","journal-title":"Commun Dis Public Health"},{"key":"2445_CR37","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1128\/CVI.00348-06","volume":"14","author":"M Koskiniemi","year":"2007","unstructured":"Koskiniemi M, Lappalainen M, Schmid DS, Rubtcova E, Loparev VN. Genotypic analysis of varicella-zoster virus and its seroprevalence in Finland. Clin Vaccine Immunol. 2007;14:1057\u201361.","journal-title":"Clin Vaccine Immunol"},{"key":"2445_CR38","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1136\/jcp.55.2.154","volume":"55","author":"G Kudesia","year":"2002","unstructured":"Kudesia G, Partridge S, Farrington CP, Soltanpoor N. Changes in age related seroprevalence of antibody to varicella zoster virus: impact on vaccine strategy. J Clin Pathol. 2002;55:154\u20135.","journal-title":"J Clin Pathol"},{"key":"2445_CR39","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1016\/j.vaccine.2010.06.004","volume":"29","author":"E Leuridan","year":"2011","unstructured":"Leuridan E, Hens N, Hutse V, Aerts M, Van Damme P. Kinetics of maternal antibodies against rubella and varicella in infants. Vaccine. 2011;29:2222\u20136.","journal-title":"Vaccine"},{"key":"2445_CR40","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1017\/S0950268804002754","volume":"132","author":"J Mossong","year":"2004","unstructured":"Mossong J, Putz L, Schneider F. Seroprevalence and force of infection of varicella-zoster virus in Luxembourg. Epidemiol Infect. 2004;132:1121\u20137.","journal-title":"Epidemiol Infect"},{"key":"2445_CR41","doi-asserted-by":"crossref","first-page":"7866","DOI":"10.1016\/j.vaccine.2007.07.036","volume":"25","author":"A Nardone","year":"2007","unstructured":"Nardone A, de Ory F, Carton M, et al. The comparative sero-epidemiology of varicella zoster virus in 11 countries in the European region. Vaccine. 2007;25:7866\u201372.","journal-title":"Vaccine"},{"key":"2445_CR42","first-page":"206","volume":"8","author":"J Oliveira","year":"1995","unstructured":"Oliveira J, da Cunha S, Corte-Real R, Sampaio L, Dais N, Melico-Silvestre A. The prevalence of measles, rubella, mumps and chickenpox antibodies in a population of health care workers. Acta Medica Port. 1995;8:206\u201316.","journal-title":"Acta Medica Port"},{"key":"2445_CR43","first-page":"155","volume":"12","author":"J Oliveira","year":"1999","unstructured":"Oliveira J, Dias N, Ferreira TM, et al. The determination of susceptibility to measles, rubella, mumps and chickenpox in students of health-related areas. Acta Medica Port. 1999;12:155\u201360.","journal-title":"Acta Medica Port"},{"key":"2445_CR44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0081881","volume":"8","author":"L Pembrey","year":"2013","unstructured":"Pembrey L, Raynor P, Griffiths P, Chaytor S, Wright J, Hall AJ. Seroprevalence of cytomegalovirus, Epstein Barr virus and varicella zoster virus among pregnant women in Bradford: a cohort study. PLoS One. 2013;8:e81881.","journal-title":"PLoS One"},{"key":"2445_CR45","doi-asserted-by":"crossref","first-page":"41","DOI":"10.21101\/cejph.a3454","volume":"16","author":"N Perez-Farinos","year":"2008","unstructured":"Perez-Farinos N, Garcia-Comas L, Ramirez-Fernandez R, et al. Seroprevalence of antibodies to varicella-zoster virus in Madrid (Spain) in the absence of vaccination. Cent Eur J Public Health. 2008;16:41\u20134.","journal-title":"Cent Eur J Public Health"},{"key":"2445_CR46","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1128\/CVI.00397-08","volume":"16","author":"D Pinquier","year":"2009","unstructured":"Pinquier D, Gagneur A, Balu L, et al. Prevalence of anti-varicella-zoster virus antibodies in French infants under 15 months of age. Clin Vaccine Immunol. 2009;16:484\u20137.","journal-title":"Clin Vaccine Immunol"},{"key":"2445_CR47","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1111\/j.1471-0528.2007.01454.x","volume":"114","author":"P Plans","year":"2007","unstructured":"Plans P, Costa J, Espunes J, Plasencia A, Salleras L. Prevalence of varicella-zoster antibodies in pregnant women in Catalonia (Spain). Rationale for varicella vaccination of women of childbearing age. BJOG. 2007;114:1122\u20137.","journal-title":"BJOG"},{"key":"2445_CR48","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1023\/A:1023038705835","volume":"18","author":"M Ringler","year":"2003","unstructured":"Ringler M, Gobel G, Most J, Weithaler K. Fully vaccinated children are rare: immunization coverage and seroprevalence in Austrian school children. Eur J Epidemiol. 2003;18:161\u201370.","journal-title":"Eur J Epidemiol"},{"key":"2445_CR49","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s10654-007-9136-z","volume":"22","author":"M Saadatian-Elahi","year":"2007","unstructured":"Saadatian-Elahi M, Mekki Y, Del Signore C, et al. Seroprevalence of varicella antibodies among pregnant women in Lyon-France. Eur J Epidemiol. 2007;22:405\u20139.","journal-title":"Eur J Epidemiol"},{"key":"2445_CR50","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s00430-007-0064-z","volume":"197","author":"L Salleras","year":"2008","unstructured":"Salleras L, Dominguez A, Plans P, et al. Seroprevalence of varicella zoster virus infection in child and adult population of Catalonia (Spain). Med Microbiol Immunol. 2008;197:329\u201333.","journal-title":"Med Microbiol Immunol"},{"key":"2445_CR51","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0264-410X(00)00178-X","volume":"19","author":"L Salleras","year":"2000","unstructured":"Salleras L, Dominguez A, Vidal J, Plans P, Salleras M, Taberner JL. Seroepidemiology of varicella-zoster virus infection in Catalonia (Spain). Rationale for universal vaccination programmes. Vaccine. 2000;19:183\u20138.","journal-title":"Vaccine"},{"key":"2445_CR52","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s00103-003-0689-z","volume":"47","author":"A Sauerbrei","year":"2004","unstructured":"Sauerbrei A, Prager J, Bischoff A, Wutzler P. Antibodies against vaccine-preventable diseases in pregnant women and their offspring. Measles, mumps, rubella, poliomyelitis, and varicella. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2004;47:10\u20135.","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"key":"2445_CR53","first-page":"495","volume":"63","author":"J Siennicka","year":"2009","unstructured":"Siennicka J, Trzcinska A, Rosinska M, Litwinska B. Seroprevalence of varicella-zoster virus in polish population. Przegl Epidemiol. 2009;63:495\u20139.","journal-title":"Przegl Epidemiol"},{"key":"2445_CR54","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1186\/1471-2458-10-360","volume":"10","author":"M Socan","year":"2010","unstructured":"Socan M, Berginc N, Lajovic J. Varicella susceptibility and transmission dynamics in Slovenia. BMC Public Health. 2010;10:360.","journal-title":"BMC Public Health"},{"key":"2445_CR55","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0025-7753(02)73353-8","volume":"119","author":"A Suarez Gonzalez","year":"2002","unstructured":"Suarez Gonzalez A, Otero Guerra L, De La Guerra GV, La Iglesia Martinez Pd P, Solis Sanchez G, Rodriguez Fernandez A. Varicella and parvovirus B19 immunity among pregnant women in Gijon, Spain. Med Clin (Barc). 2002;119:171\u20133.","journal-title":"Med Clin (Barc)"},{"key":"2445_CR56","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jcv.2006.07.012","volume":"37","author":"A Svahn","year":"2006","unstructured":"Svahn A, Berggren J, Parke A, Storsaeter J, Thorstensson R, Linde A. Changes in seroprevalence to four herpesviruses over 30 years in Swedish children aged 9-12 years. J Clin Virol. 2006;37:118\u201323.","journal-title":"J Clin Virol"},{"key":"2445_CR57","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1017\/S0950268807008497","volume":"135","author":"YS Talukder","year":"2007","unstructured":"Talukder YS, Kafatos G, Pinot de Moira A, et al. The seroepidemiology of varicella zoster virus among pregnant Bangladeshi and white British women in the London borough of tower hamlets, UK. Epidemiol Infect. 2007;135:1344\u201353.","journal-title":"Epidemiol Infect"},{"key":"2445_CR58","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1007\/s00431-002-1053-2","volume":"161","author":"N Thiry","year":"2002","unstructured":"Thiry N, Beutels P, Shkedy Z, et al. The seroepidemiology of primary varicella-zoster virus infection in Flanders (Belgium). Eur J Pediatr. 2002;161:588\u201393.","journal-title":"Eur J Pediatr"},{"key":"2445_CR59","first-page":"113","volume":"95","author":"H Thorarinsdottir","year":"2009","unstructured":"Thorarinsdottir H, Love A, Laxdal T, Gudnason T, Haraldsson A. Varicella in Icelandic children--epidemiology and complications. Laeknabladid. 2009;95:113\u20138.","journal-title":"Laeknabladid"},{"key":"2445_CR60","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1086\/516657","volume":"28","author":"A Trevisan","year":"2007","unstructured":"Trevisan A, Frasson C, Morandin M, et al. Immunity against infectious diseases: predictive value of self-reported history of vaccination and disease. Infect Control Hosp Epidemiol. 2007;28:564\u20139.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"2445_CR61","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.vaccine.2005.07.062","volume":"24","author":"A Trevisan","year":"2006","unstructured":"Trevisan A, Morandin M, Frasson C, et al. Prevalence of childhood exanthematic disease antibodies in paramedical students: need of vaccination. Vaccine. 2006;24:171\u20136.","journal-title":"Vaccine"},{"key":"2445_CR62","doi-asserted-by":"crossref","first-page":"5127","DOI":"10.1016\/j.vaccine.2013.08.029","volume":"31","author":"A Lier van","year":"2013","unstructured":"van Lier A, Smits G, Mollema L, et al. Varicella zoster virus infection occurs at a relatively young age in The Netherlands. Vaccine. 2013;31:5127\u201333.","journal-title":"Vaccine"},{"key":"2445_CR63","doi-asserted-by":"crossref","unstructured":"van Rijckevorsel GG, Bovee LP, Damen M, Sonder GJ, Schim van der Loeff MF, van den Hoek A. Increased seroprevalence of IgG-class antibodies against cytomegalovirus, parvovirus B19, and varicella-zoster virus in women working in child day care. BMC Public Health. 2012;12:475.","DOI":"10.1186\/1471-2458-12-475"},{"key":"2445_CR64","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/1471-2334-12-140","volume":"12","author":"GG Rijckevorsel van","year":"2012","unstructured":"van Rijckevorsel GG, Damen M, Sonder GJ, van der Loeff MF, van den Hoek A. Seroprevalence of varicella-zoster virus and predictors for seronegativity in the Amsterdam adult population. BMC Infect Dis. 2012;12:140.","journal-title":"BMC Infect Dis"},{"key":"2445_CR65","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1136\/oem.57.9.621","volume":"57","author":"G Vandersmissen","year":"2000","unstructured":"Vandersmissen G, Moens G, Vranckx R, de Schryver A, Jacques P. Occupational risk of infection by varicella zoster virus in Belgian healthcare workers: a seroprevalence study. Occup Environ Med. 2000;57:621\u20136.","journal-title":"Occup Environ Med"},{"key":"2445_CR66","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s00404-012-2398-z","volume":"286","author":"T Vilibic-Cavlek","year":"2012","unstructured":"Vilibic-Cavlek T, Ljubin-Sternak S, Kolaric B, et al. Immunity to varicella-zoster virus in Croatian women of reproductive age targeted for serology testing. Arch Gynecol Obstet. 2012;286:901\u20134.","journal-title":"Arch Gynecol Obstet"},{"key":"2445_CR67","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1017\/S0950268804003140","volume":"132","author":"AJ Vyse","year":"2004","unstructured":"Vyse AJ, Gay NJ, Hesketh LM, Morgan-Capner P, Miller E. Seroprevalence of antibody to varicella zoster virus in England and Wales in children and young adults. Epidemiol Infect. 2004;132:1129\u201334.","journal-title":"Epidemiol Infect"},{"key":"2445_CR68","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0264-410X(01)00276-6","volume":"20","author":"P Wutzler","year":"2001","unstructured":"Wutzler P, Farber I, Wagenpfeil S, Bisanz H, Tischer A. Seroprevalence of varicella-zoster virus in the German population. Vaccine. 2001;20:121\u20134.","journal-title":"Vaccine"},{"key":"2445_CR69","unstructured":"HPSC Annual Epidemiological Report 2012. Available from: http:\/\/www.hpsc.ie\/A-Z\/VaccinePreventable\/VaricellaChickenpox\/SurveillanceReports\/AnnualReports\/ ."},{"key":"2445_CR70","unstructured":"HPSC Annual Epidemiological Report 2013. Available from: http:\/\/www.hpsc.ie\/A-Z\/VaccinePreventable\/VaricellaChickenpox\/SurveillanceReports\/AnnualReports\/ ."},{"key":"2445_CR71","unstructured":"HPSC Annual Epidemiological Report 2014. Available from: http:\/\/www.hpsc.ie\/A-Z\/VaccinePreventable\/VaricellaChickenpox\/SurveillanceReports\/AnnualReports\/ ."},{"key":"2445_CR72","unstructured":"National Archive SDO data, Ministry of Health, General Directorate of Health and Planning, VI Office, 2001-2005."},{"key":"2445_CR73","first-page":"3040","volume":"107","author":"R Bennet","year":"2010","unstructured":"Bennet R, Bogdanovic G, Giske CG, Eriksson M. More severe bacterial infections could be prevented with vaccine. Rotavirus, influenza and varicella cause thousands of hospital admissions. Lakartidningen. 2010;107:3040\u20133.","journal-title":"Lakartidningen"},{"key":"2445_CR74","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1017\/S0950268811002640","volume":"140","author":"J Bilcke","year":"2012","unstructured":"Bilcke J, Ogunjimi B, Marais C, et al. The health and economic burden of chickenpox and herpes zoster in Belgium. Epidemiol Infect. 2012;140:2096\u2013109.","journal-title":"Epidemiol Infect"},{"key":"2445_CR75","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1136\/archdischild-2015-308283","volume":"101","author":"S Blumental","year":"2016","unstructured":"Blumental S, Sabbe M, Lepage P, Belgian Group for V. Varicella paediatric hospitalisations in Belgium: a 1-year national survey. Arch Dis Child. 2016;101:16\u201322.","journal-title":"Arch Dis Child"},{"key":"2445_CR76","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1017\/S0950268802007720","volume":"129","author":"PY Boelle","year":"2002","unstructured":"Boelle PY, Hanslik T. Varicella in non-immune persons: incidence, hospitalization and mortality rates. Epidemiol Infect. 2002;129:599\u2013606.","journal-title":"Epidemiol Infect"},{"key":"2445_CR77","first-page":"30","volume":"8","author":"I Bonmarin","year":"2005","unstructured":"Bonmarin I, Ndiaye B, Seringe E, Levy-Bruhl D. The epidemiology of varicella in France. Bull Epidemiol Hebd. 2005;8:30\u20132.","journal-title":"Bull Epidemiol Hebd"},{"key":"2445_CR78","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1007\/s15010-007-6248-z","volume":"35","author":"F Bonsignori","year":"2007","unstructured":"Bonsignori F, Chiappini E, Frenos S, Peraldo M, Galli L, de Martino M. Hospitalization rates for complicated and uncomplicated chickenpox in a poorly vaccined pediatric population. Infection. 2007;35:444\u201350.","journal-title":"Infection"},{"key":"2445_CR79","first-page":"282","volume":"3","author":"JC Bramley","year":"2000","unstructured":"Bramley JC, Jones IG. Epidemiology of chickenpox in Scotland: 1981 to 1998. Commun Dis Public Health. 2000;3:282\u20137.","journal-title":"Commun Dis Public Health"},{"issue":"Suppl 1","key":"2445_CR80","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1002\/jmv.10313","volume":"70","author":"M Brisson","year":"2003","unstructured":"Brisson M, Edmunds WJ. Epidemiology of Varicella-zoster virus in England and Wales. J Med Virol. 2003;70(Suppl 1):S9\u201314.","journal-title":"J Med Virol"},{"key":"2445_CR81","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1017\/S0950268801005921","volume":"127","author":"M Brisson","year":"2001","unstructured":"Brisson M, Edmunds WJ, Law B, et al. Epidemiology of varicella zoster virus infection in Canada and the United Kingdom. Epidemiol Infect. 2001;127:305\u201314.","journal-title":"Epidemiol Infect"},{"key":"2445_CR82","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0052016","volume":"7","author":"E Critselis","year":"2012","unstructured":"Critselis E, Nastos PT, Theodoridou K, et al. Time trends in pediatric hospitalizations for varicella infection are associated with climatic changes: a 22-year retrospective study in a tertiary Greek referral center. PLoS One. 2012;7:e52016.","journal-title":"PLoS One"},{"key":"2445_CR83","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/S0264-410X(98)00394-6","volume":"17","author":"J Diez Domingo","year":"1999","unstructured":"Diez Domingo J, Ridao M, Latour J, Ballester A, Morant A. A cost benefit analysis of routine varicella vaccination in Spain. Vaccine. 1999;17:1306\u201311.","journal-title":"Vaccine"},{"key":"2445_CR84","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1017\/S0950268806006467","volume":"135","author":"F Dubos","year":"2007","unstructured":"Dubos F, Grandbastien B, Hue V, Martinot A. Epidemiology of hospital admissions for paediatric varicella infections: a one-year prospective survey in the pre-vaccine era. Epidemiol Infect. 2007;135:131\u20138.","journal-title":"Epidemiol Infect"},{"key":"2445_CR85","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1056\/NEJM200504283521718","volume":"352","author":"R Giacchino","year":"2005","unstructured":"Giacchino R, Losurdo G, Castagnola E. Decline in mortality with varicella vaccination. N Engl J Med. 2005;352:1819.","journal-title":"N Engl J Med"},{"key":"2445_CR86","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1023\/B:EJEP.0000036791.43264.84","volume":"19","author":"A Gil","year":"2004","unstructured":"Gil A, Gonzalez A, Oyaguez I, Martin MS, Carrasco P. The burden of severe varicella in Spain, 1995--2000 period. Eur J Epidemiol. 2004;19:699\u2013702.","journal-title":"Eur J Epidemiol"},{"key":"2445_CR87","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0264-410X(01)00370-X","volume":"20","author":"A Gil","year":"2001","unstructured":"Gil A, Oyaguez I, Carrasco P, Gonzalez A. Epidemiology of primary varicella hospitalizations in Spain. Vaccine. 2001;20:295\u20138.","journal-title":"Vaccine"},{"key":"2445_CR88","doi-asserted-by":"crossref","first-page":"3947","DOI":"10.1016\/j.vaccine.2004.04.004","volume":"22","author":"A Gil","year":"2004","unstructured":"Gil A, San-Martin M, Carrasco P, Gonzalez A. Epidemiology of severe varicella-zoster virus infection in Spain. Vaccine. 2004;22:3947\u201351.","journal-title":"Vaccine"},{"key":"2445_CR89","first-page":"580","volume":"106","author":"P Grimheden","year":"2009","unstructured":"Grimheden P, Bennet R, Hjern A, Nilsson A, Eriksson M. Chickenpox not always a harmless child disease. General vaccination in Sweden can prevent significant morbidity. Lakartidningen. 2009;106:580\u20132.","journal-title":"Lakartidningen"},{"key":"2445_CR90","doi-asserted-by":"crossref","first-page":"659","DOI":"10.4161\/hv.6.8.12014","volume":"6","author":"JM Guillen","year":"2010","unstructured":"Guillen JM, Gil-Prieto R, Alvaro A, Gil A. Burden of adult varicella hospitalizations in Spain (2001-2007). Hum Vaccin. 2010;6:659\u201363.","journal-title":"Hum Vaccin"},{"key":"2445_CR91","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1017\/S0950268808001131","volume":"137","author":"JM Guillen","year":"2009","unstructured":"Guillen JM, Samaniego-Colmenero Mde L, Hernandez-Barrera V, Gil A. Varicella paediatric hospitalizations in Spain. Epidemiol Infect. 2009;137:519\u201325.","journal-title":"Epidemiol Infect"},{"key":"2445_CR92","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1097\/INF.0b013e31817eb821","volume":"27","author":"D Hervas","year":"2008","unstructured":"Hervas D, Osona B, Masip C, Yeste S, Figuerola J, Hervas JA. Risk of varicella complications in children treated with inhaled steroids. Pediatr Infect Dis J. 2008;27:1113\u20134.","journal-title":"Pediatr Infect Dis J"},{"key":"2445_CR93","doi-asserted-by":"crossref","first-page":"19579","DOI":"10.2807\/ese.15.21.19579-en","volume":"15","author":"E Jelastopulu","year":"2010","unstructured":"Jelastopulu E, Merekoulias G, Alexopoulos EC. Underreporting of communicable diseases in the prefecture of Achaia, western Greece, 1999-2004 - missed opportunities for early intervention. Euro Surveill. 2010;15:19579.","journal-title":"Euro Surveill"},{"key":"2445_CR94","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/INF.0b013e3181586665","volume":"27","author":"JG Liese","year":"2008","unstructured":"Liese JG, Grote V, Rosenfeld E, et al. The burden of varicella complications before the introduction of routine varicella vaccination in Germany. Pediatr Infect Dis J. 2008;27:119\u201324.","journal-title":"Pediatr Infect Dis J"},{"key":"2445_CR95","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1111\/j.1651-2227.2007.00465.x","volume":"96","author":"S Marchetto","year":"2007","unstructured":"Marchetto S, de Benedictis FM, de Martino M, et al. Epidemiology of hospital admissions for chickenpox in children: an Italian multicentre study in the pre-vaccine era. Acta Paediatr. 2007;96:1490\u20133.","journal-title":"Acta Paediatr"},{"key":"2445_CR96","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3109\/00365549609049061","volume":"28","author":"A Nilsson","year":"1996","unstructured":"Nilsson A, Ortqvist A. Severe varicella pneumonia in adults in Stockholm County 1980-1989. Scand J Infect Dis. 1996;28:121\u20133.","journal-title":"Scand J Infect Dis"},{"key":"2445_CR97","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1590\/S1135-57272009000500012","volume":"83","author":"I Pena-Rey","year":"2009","unstructured":"Pena-Rey I, Martinez de Aragon MV, Villaverde Hueso A, Terres Arellano M, Alcalde Cabero E, Suarez Rodriguez B. Epidemiology of varicella in spain pre-and post-vaccination periods. Rev Esp Salud Publica. 2009;83:711\u201324.","journal-title":"Rev Esp Salud Publica"},{"key":"2445_CR98","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S1695-4033(03)78170-3","volume":"59","author":"EG Perez-Yarza","year":"2003","unstructured":"Perez-Yarza EG, Arranz L, Alustiza J, et al. Hospital admissions for varicella complications in children aged less than 15 years old. An Pediatr (Barc). 2003;59:229\u201333.","journal-title":"An Pediatr (Barc)"},{"key":"2445_CR99","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/1471-2334-12-110","volume":"12","author":"JG Pierik","year":"2012","unstructured":"Pierik JG, Gumbs PD, Fortanier SA, Van Steenwijk PC, Postma MJ. Epidemiological characteristics and societal burden of varicella zoster virus in the Netherlands. BMC Infect Dis. 2012;12:110.","journal-title":"BMC Infect Dis"},{"key":"2445_CR100","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.pediatrneurol.2009.07.012","volume":"42","author":"AL Rack","year":"2010","unstructured":"Rack AL, Grote V, Streng A, et al. Neurologic varicella complications before routine immunization in Germany. Pediatr Neurol. 2010;42:40\u20138.","journal-title":"Pediatr Neurol"},{"key":"2445_CR101","first-page":"201","volume":"68","author":"J Rogalska","year":"2014","unstructured":"Rogalska J, Paradowska-Stankiewicz I. Chickenpox in Poland in 2012. Przegl Epidemiol. 2014;68:201\u20134. 323-204","journal-title":"Przegl Epidemiol"},{"key":"2445_CR102","unstructured":"Schurink-van\u2019t Klooster TM, de Melker HE. The National Immunisation Programme in the Netherlands; Surveillance and developments in 2014\u20132015. Bilthoven: Rijksinstituut voor Volksgezondheid en Milieu (RIVM); 2015 (RIVM rapport 2015\u20130134). Available from: http:\/\/www.rivm.nl\/bibliotheek\/rapporten\/2015-0134.pdf ."},{"key":"2445_CR103","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00431-005-0043-6","volume":"165","author":"M Theodoridou","year":"2006","unstructured":"Theodoridou M, Laina I, Hadjichristodoulou C, Syriopoulou V. Varicella-related complications and hospitalisations in a tertiary pediatric medical center before vaccine introduction. Eur J Pediatr. 2006;165:273\u20134.","journal-title":"Eur J Pediatr"},{"key":"2445_CR104","doi-asserted-by":"crossref","first-page":"3517","DOI":"10.1016\/j.vaccine.2014.04.034","volume":"32","author":"A Lier van","year":"2014","unstructured":"van Lier A, van Erp J, Donker GA, van der Maas NA, Sturkenboom MC, de Melker HE. Low varicella-related consultation rate in the Netherlands in primary care data. Vaccine. 2014;32:3517\u201324.","journal-title":"Vaccine"},{"key":"2445_CR105","unstructured":"R\u00e9seau Sentinelles. Bilan annuel 2008\u20132014. Available from: https:\/\/websenti.u707.jussieu.fr\/sentiweb\/?rub=39 ."},{"key":"2445_CR106","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1097\/00006454-200208000-00013","volume":"21","author":"ML Ciofi Degli Atti","year":"2002","unstructured":"Ciofi Degli Atti ML, Salmaso S, Bella A, et al. Pediatric sentinel surveillance of vaccine-preventable diseases in Italy. Pediatr Infect Dis J. 2002;21:763\u20138.","journal-title":"Pediatr Infect Dis J"},{"key":"2445_CR107","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1097\/00006454-199905000-00004","volume":"18","author":"P Fornaro","year":"1999","unstructured":"Fornaro P, Gandini F, Marin M, et al. Epidemiology and cost analysis of varicella in Italy: results of a sentinel study in the pediatric practice. Italian sentinel group on pediatric infectious diseases. Pediatr Infect Dis J. 1999;18:414\u20139.","journal-title":"Pediatr Infect Dis J"},{"key":"2445_CR108","doi-asserted-by":"crossref","first-page":"843","DOI":"10.4161\/hv.9897","volume":"5","author":"A Iseli","year":"2009","unstructured":"Iseli A, Aebi C, Banz K, Brunner M, Schmutz AM, Heininger U. Prospective surveillance of varicella-zoster virus infections in an out-patient setting in Switzerland. Hum Vaccin. 2009;5:843\u20136.","journal-title":"Hum Vaccin"},{"key":"2445_CR109","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1136\/adc.2002.021618","volume":"89","author":"GL Lowe","year":"2004","unstructured":"Lowe GL, Salmon RL, Thomas DR, Evans MR. Declining incidence of chickenpox in the absence of universal childhood immunisation. Arch Dis Child. 2004;89:966\u20139.","journal-title":"Arch Dis Child"},{"key":"2445_CR110","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/00001648-200301000-00024","volume":"14","author":"A Nicolosi","year":"2003","unstructured":"Nicolosi A, Sturkenboom M, Mannino S, Arpinelli F, Cantarutti L, Giaquinto C. The incidence of varicella: correction of a common error. Epidemiology. 2003;14:99\u2013102.","journal-title":"Epidemiology"},{"key":"2445_CR111","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1007\/s001050050476","volume":"47","author":"E Paul","year":"1996","unstructured":"Paul E, Thiel T. Epidemiology of varicella zoster infection. Results of a prospective study in the Ansbach area. Hautarzt. 1996;47:604\u20139.","journal-title":"Hautarzt"},{"key":"2445_CR112","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1471-2334-7-59","volume":"7","author":"N Perez-Farinos","year":"2007","unstructured":"Perez-Farinos N, Ordobas M, Garcia-Fernandez C, et al. Varicella and herpes zoster in Madrid, based on the sentinel general practitioner network: 1997-2004. BMC Infect Dis. 2007;7:59.","journal-title":"BMC Infect Dis"},{"key":"2445_CR113","first-page":"213","volume":"3","author":"AM Ross","year":"2000","unstructured":"Ross AM, Fleming DM. Chickenpox increasingly affects preschool children. Commun Dis Public Health. 2000;3:213\u20135.","journal-title":"Commun Dis Public Health"},{"key":"2445_CR114","unstructured":"Sabbe M, Braeye T, Hue D, Grammens T, Qouilin S. Maladies infectieuses pediatriques a prevention vaccinale. Tendances et developpements en Belgique et dans les Communautes, 2012. Institut Scientifique de Sante Publique. Available from: https:\/\/epidemio.wiv-isp.be\/ID\/diseases\/Documents\/VPD_Rapport_2012_FR.pdf ."},{"key":"2445_CR115","unstructured":"Sabbe M, Vanthomme K, Top G, Van Casteren V. Epidemiologie van windpokken en zona vastgesteld door huisartsen: 2006\u20132010. Vlaams Infektieziekbulletin 82\/2012\/4. Available from:\u00a0 https:\/\/www.zorg-en-gezondheid.be\/sites\/default\/files\/atoms\/files\/2012-4_82_Epidemiologie_zona_windpok_M.%20Sabbe.pdf ."},{"key":"2445_CR116","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.puhe.2010.02.005","volume":"124","author":"D Stefler","year":"2010","unstructured":"Stefler D, Bhopal R. Comparison of the Hungarian and Scottish communicable disease control systems: lessons for a convergent European Community. Public Health. 2010;124:167\u201373.","journal-title":"Public Health"},{"key":"2445_CR117","doi-asserted-by":"crossref","first-page":"99","DOI":"10.4321\/S1137-66272003000100008","volume":"26","author":"M Urtiaga","year":"2003","unstructured":"Urtiaga M, Irisarri F, Zabala A. Diseases of compulsory notification (DCN) in Navarra. 2002. An Sist Sanit Navar. 2003;26:99\u2013108.","journal-title":"An Sist Sanit Navar"},{"key":"2445_CR118","unstructured":"INSERM. Centre d\u2019epid\u00e9miologie sur les causes m\u00e9dicales de d\u00e9c\u00e8s (C\u00e9piDC): Base de donn\u00e9es sur les causes de d\u00e9c\u00e8s. Available from: http:\/\/www.cepidc.inserm.fr\/inserm\/html\/index2.htm ."},{"key":"2445_CR119","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1136\/adc.2007.123232","volume":"92","author":"JC Cameron","year":"2007","unstructured":"Cameron JC, Allan G, Johnston F, Finn A, Heath PT, Booy R. Severe complications of chickenpox in hospitalised children in the UK and Ireland. Arch Dis Child. 2007;92:1062\u20136.","journal-title":"Arch Dis Child"},{"key":"2445_CR120","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1651-2227.2007.00595.x","volume":"97","author":"V Grote","year":"2008","unstructured":"Grote V, von Kries R, Springer W, Hammersen G, Kreth HW, Liese J. Varicella-related deaths in children and adolescents--Germany 2003-2004. Acta Paediatr. 2008;97:187\u201392.","journal-title":"Acta Paediatr"},{"key":"2445_CR121","doi-asserted-by":"crossref","first-page":"e355","DOI":"10.1097\/INF.0b013e3182930694","volume":"32","author":"M Lantto","year":"2013","unstructured":"Lantto M, Renko M, Uhari M. Changes in infectious disease mortality in children during the past three decades. Pediatr Infect Dis J. 2013;32:e355\u20139.","journal-title":"Pediatr Infect Dis J"},{"key":"2445_CR122","unstructured":"EUVAC.NET. Varicella surveillance report 2008\u20132009. Available from: http:\/\/ecdc.europa.eu\/en\/publications\/Publications\/varicella_report_2008_2009_euvacnet.pdf ."},{"key":"2445_CR123","unstructured":"EUVAC.NET. Varicella surveillance report 2010. Available from: http:\/\/ecdc.europa.eu\/en\/publications\/Publications\/varicella_report_2010_euvacnet.pdf ."},{"key":"2445_CR124","volume":"10","author":"V Arama","year":"2005","unstructured":"Arama V, Rafila A, Streinu-Cercel A, et al. Varicella in Romania: epidemiological trends, 1986-2004. Euro Surveill. 2005;10:E050811.050816.","journal-title":"Euro Surveill"},{"key":"2445_CR125","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/1471-2334-9-150","volume":"9","author":"V Baldo","year":"2009","unstructured":"Baldo V, Baldovin T, Russo F, et al. Varicella: epidemiological aspects and vaccination coverage in the Veneto region. BMC Infect Dis. 2009;9:150.","journal-title":"BMC Infect Dis"},{"key":"2445_CR126","first-page":"195","volume":"67","author":"M Lipke","year":"2013","unstructured":"Lipke M, Paradowska-Stankiewicz I. Chickenpox in Poland in 2011. Przegl Epidemiol. 2013;67:195\u20137. 317-198","journal-title":"Przegl Epidemiol"},{"key":"2445_CR127","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s00430-002-0123-4","volume":"191","author":"P Wutzler","year":"2002","unstructured":"Wutzler P, Neiss A, Banz K, Goertz A, Bisanz H. Can varicella be eliminated by vaccination? Potential clinical and economic effects of universal childhood varicella immunisation in Germany. Med Microbiol Immunol. 2002;191:89\u201396.","journal-title":"Med Microbiol Immunol"},{"key":"2445_CR128","doi-asserted-by":"crossref","unstructured":"Baldo V, Ferro A, Napoletano G, et al. Universal varicella vaccination in the Veneto region, Italy: launch of a programme targeting all children aged 14 months and susceptible adolescents. Euro Surveill. 2007;12:E071101 071103.","DOI":"10.2807\/esw.12.44.03299-en"},{"key":"2445_CR129","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1017\/S0950268801006264","volume":"127","author":"MP Munoz","year":"2001","unstructured":"Munoz MP, Dominguez A, Salleras L. Estimated varicella incidence on the basis of a seroprevalence survey. Epidemiol Infect. 2001;127:501\u20137.","journal-title":"Epidemiol Infect"},{"key":"2445_CR130","doi-asserted-by":"crossref","DOI":"10.1542\/peds.108.5.e79","volume":"108","author":"C Ziebold","year":"2001","unstructured":"Ziebold C, von Kries R, Lang R, Weigl J, Schmitt HJ. Severe complications of varicella in previously healthy children in Germany: a 1-year survey. Pediatrics. 2001;108:E79.","journal-title":"Pediatrics"},{"key":"2445_CR131","doi-asserted-by":"crossref","unstructured":"Wolleswinkel-van den Bosch JH, Speets AM, Rumke HC, Gumbs PD, Fortanier SC. The burden of varicella from a parent\u2019s perspective and its societal impact in The Netherlands: an internet survey. BMC Infect Dis. 2011;11:320.","DOI":"10.1186\/1471-2334-11-320"},{"issue":"Suppl 1","key":"2445_CR132","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1086\/514275","volume":"178","author":"P Saddier","year":"1998","unstructured":"Saddier P, Floret D, Guess HA, et al. Cost of varicella in France: a study in day care centers. J Infect Dis. 1998;178(Suppl 1):S58\u201363.","journal-title":"J Infect Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-017-2445-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T14:21:46Z","timestamp":1659018106000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-017-2445-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,18]]},"references-count":132,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["2445"],"URL":"https:\/\/doi.org\/10.1186\/s12879-017-2445-2","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,18]]},"article-number":"353"}}